NASDAQ:PRE Prenetics Global Q2 2024 Earnings Report $22.76 -0.21 (-0.91%) Closing price 04:00 PM EasternExtended Trading$22.77 +0.01 (+0.05%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Prenetics Global EPS ResultsActual EPS-$0.88Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/APrenetics Global Revenue ResultsActual Revenue$5.94 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/APrenetics Global Announcement DetailsQuarterQ2 2024Date10/7/2024TimeN/AConference Call DateN/AConference Call TimeN/AUpcoming EarningsPrenetics Global's Q3 2026 earnings is estimated for Monday, November 9, 2026, based on past reporting schedules, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesEarnings HistoryCompany Profile Prenetics Global Earnings HeadlinesComparing Prenetics Global (NASDAQ:PRE) & Lifevantage (NASDAQ:LFVN)September 27 at 8:44 AM | americanbankingnews.comPrenetics Global Limited (NASDAQ:PRE) Stock Now Rated "Moderate Buy" by Wall Street AnalystsSeptember 25 at 4:15 AM | americanbankingnews.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.September 28 at 1:00 AM | Porter & Company (Ad)Prenetics Global (NASDAQ:PRE) Coverage Initiated at Craig HallumSeptember 19, 2026 | americanbankingnews.comCraig-Hallum initiates coverage of Prenetics Global with buySeptember 18, 2026 | msn.comCraig-Hallum Initiates Prenetics Global With Buy Rating, $40 Price TargetSeptember 17, 2026 | marketscreener.comMSee More Prenetics Global Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Prenetics Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prenetics Global and other key companies, straight to your email. Email Address About Prenetics GlobalPrenetics Global (NASDAQ:PRE) is a health sciences and genomics company focused on consumer health, clinical diagnostics and precision oncology. The company develops and commercializes genetic testing and related healthcare solutions intended to help individuals and clinicians better understand disease risk, make informed health decisions and support personalized care. Prenetics is known for CircleDNA, a consumer genetic testing platform that provides information related to ancestry, wellness, nutrition, lifestyle and selected health risks. The company also provides clinical and oncology-focused testing services, including genomic analysis designed to support cancer treatment decisions and the development of personalized medicine. Founded in 2014, Prenetics has served customers and healthcare organizations across markets including Asia, the United Kingdom and the United States. The company has expanded its capabilities through the development and acquisition of precision oncology and genomic testing businesses. Prenetics is led by founder and Chief Executive Officer Danny Yeung and is listed on the Nasdaq Stock Market under the symbol PRE.View Prenetics Global ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Brewing Trouble? Starbucks Spills the Beans on 250 Store ClosuresMarketBeat Week in Review – 09/21 - 09/25Analyst Rating Boosts May Signal More Upside for These 3 Stocks3 Stocks Under the Microscope After Large Insider Sales3 Healthcare Stocks Showing Why the Sector Still Has Momentum2 Cybersecurity Stocks Breaking Out as AI Continues to Be a TailwindFertilizer Prices Keep Climbing: 3 Stocks Still Trading at a Discount Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
